Gliomas with high expression levels of ANXA1 showed a significant poor prognosis for overall survival (OS) in both gliomas and LGGs (log-rank test, p < 1.0e-4, Figures 6A,B). The gene discussed is ANXA1; the disease is central nervous system cancer.